✦ LIBER ✦

Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma

✍ Scribed by Ewald, Florian; Grabinski, Nicole; Grottke, Astrid; Windhorst, Sabine; Nörz, Dominik; Carstensen, Lisa; Staufer, Katharina; Hofmann, Bianca T.; Diehl, Frank; David, Kerstin; Schumacher, Udo; Nashan, Björn; Jücker, Manfred

Book ID: 120975822
Publisher: John Wiley and Sons
Year: 2013
Tongue: French
Weight: 919 KB
Volume: 133
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.28214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-99 The mTOR (mammalian target of rapam

O-99 The mTOR (mammalian target of rapamycin) inhibitor RAD001 (Everolimus) is safe and reduces proliferation in postmenopausal women with breast cancer

✍ E.J. Macaskill; J.M.S. Bartlett; L. Renshaw; D. Faratian; S. White; F.M. Campbel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Targeting the PI3K/AKT/mTOR and Raf/MEK/

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

✍ Saini, Kamal S.; Loi, Sherene; de Azambuja, Evandro; Metzger-Filho, Otto; Saini, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 924 KB